{"gene":"TRAF3","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":1995,"finding":"TRAF3 (then called CRAF1) was identified as a direct binding partner of the CD40 cytoplasmic tail; the TRAF-C domain of TRAF3 was necessary and sufficient for CD40 binding and homodimerization.","method":"Yeast two-hybrid screen; domain deletion analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid plus domain-deletion mapping, founding paper replicated widely","pmids":["7533327"],"is_preprint":false},{"year":2005,"finding":"TRAF3 is recruited to TLR adaptor MyD88-containing signaling complexes and is essential for induction of type I interferons and IL-10 but dispensable for pro-inflammatory cytokines; TRAF3 is required to recruit TBK1 into TIR signaling complexes.","method":"Biochemical isolation of dimerized-adaptor signaling complexes; TRAF3-deficient myeloid cells from knockout mice; cytokine measurements","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal complex isolation, genetic knockout with defined cytokine phenotypes, replicated in companion paper","pmids":["16306937"],"is_preprint":false},{"year":2005,"finding":"TRAF3 associates with TLR adaptors TRIF and IRAK1, as well as downstream IRF3/7 kinases TBK1 and IKK-ε, placing TRAF3 as a critical link between TLR adaptors and kinases required for IRF activation and type I IFN production; TRAF3-deficient fibroblasts are also defective in TLR-independent type I IFN responses to direct virus infection.","method":"Co-immunoprecipitation; TRAF3-deficient cells; virus infection assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, genetic KO with defined phenotypes, two independent pathways tested","pmids":["16306936"],"is_preprint":false},{"year":2006,"finding":"TRAF3 directly interacts with the MAVS/Cardif adaptor through a TRAF-interaction motif (TIM) in Cardif and the TRAF domain of TRAF3; mutation of two critical amino acids in the TRAF domain abolishes both Cardif binding and TRAF3-dependent IFN production after viral infection.","method":"In vitro binding assays; site-directed mutagenesis of TRAF domain; IFN induction assays","journal":"The EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding reconstitution plus mutagenesis with functional IFN readout, single lab","pmids":["16858409"],"is_preprint":false},{"year":2006,"finding":"Loss of TRAF3 results in constitutive non-canonical NF-κB activity and profound accumulation of NF-κB-inducing kinase (NIK) in TRAF3-deficient cells; the early postnatal lethality of TRAF3-knockout mice is rescued by compound loss of the non-canonical NF-κB p100 gene, genetically establishing TRAF3 as a critical negative modulator of the non-canonical NF-κB pathway.","method":"Genetic epistasis (TRAF3-/-;p100-/- double-knockout rescue); Western blotting for NIK; B cell phenotyping","journal":"The Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis (double-mutant rescue), multiple orthogonal readouts","pmids":["17015635"],"is_preprint":false},{"year":2008,"finding":"TRAF3 is constitutively degraded in a TRAF2- and cIAP1/2-dependent manner; receptor (CD40 or BAFF-R) activation causes cIAP1/2-mediated K48-linked ubiquitination and proteasomal degradation of TRAF3, which releases NIK from the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, leading to NIK stabilization and NF-κB2-p100 processing.","method":"Ubiquitination assays; cIAP1/2 and TRAF2 knockouts; receptor stimulation experiments; proteasome inhibitor studies","journal":"Nature Immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic tools, ubiquitination reconstitution, mechanistically defined E3 ligase activity, widely replicated","pmids":["18997792"],"is_preprint":false},{"year":2009,"finding":"Deubiquitinating enzymes OTUB1 and OTUB2 interact with TRAF3, remove ubiquitin from TRAF3, and negatively regulate virus-triggered type I IFN induction; overexpression inhibits IRF3 and NF-κB activation while knockdown has the opposite effect.","method":"Co-immunoprecipitation; ubiquitination assay; overexpression/knockdown; virus infection","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus functional ubiquitination assay, single lab, two orthogonal approaches","pmids":["19996094"],"is_preprint":false},{"year":2010,"finding":"A charge-repulsion mutation in the receptor-binding crevice of TRAF3 ablated binding of both LTβR and NIK, suggesting they share a common recognition site; ligand-activated LTβR competitively displaces NIK from TRAF3, and recruited TRAF3/TRAF2 redirects ubiquitin ligase activity to polyubiquitinate TRAF3 and TRAF2 for proteasomal degradation; stimulus-dependent TRAF3 degradation required the RING domain of TRAF2 (not TRAF3).","method":"Site-directed mutagenesis; co-immunoprecipitation; ubiquitination assay; proteasome inhibitor studies","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with binding and ubiquitination reconstitution experiments, multiple orthogonal methods","pmids":["20348096"],"is_preprint":false},{"year":2010,"finding":"TRAF3 negatively regulates both canonical and non-canonical NF-κB signaling by LTβR via two distinct mechanisms: by competitively blocking TRAF2 recruitment to the activated receptor (thereby inhibiting canonical IκBα phosphorylation) and by autonomously suppressing non-canonical NF-κB components (NIK, p100, RelB) independent of receptor stimulation.","method":"siRNA-mediated TRAF3 depletion; Western blotting; receptor-specific signaling assays; co-immunoprecipitation","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — siRNA plus immunoprecipitation, single lab, two orthogonal methods","pmids":["20185819"],"is_preprint":false},{"year":2014,"finding":"NEDD4 E3 ubiquitin ligase constitutively interacts with CD40 and mediates K63-linked ubiquitination of TRAF3; this ubiquitination of TRAF3 by NEDD4 is critical for CD40-mediated AKT activation.","method":"Co-immunoprecipitation; K63-linked ubiquitination assay; AKT phosphorylation readout; genetic knockdown","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and ubiquitination assay, single lab, functional AKT readout","pmids":["25072696"],"is_preprint":false},{"year":2016,"finding":"Intracellular osteopontin (iOPN) interacts with TRAF3 via its C-terminal fragment and inhibits Triad3A-mediated K48-linked polyubiquitination and degradation of TRAF3, thereby stabilizing TRAF3 and promoting antiviral type I IFN production.","method":"Co-immunoprecipitation; ubiquitination assay; OPN-deficient mice; virus infection assay","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and ubiquitination assay with genetic knockout model, single lab","pmids":["27026194"],"is_preprint":false},{"year":2016,"finding":"TRAF3 inhibits IL-6 receptor signaling in B cells by facilitating the association of phosphatase PTPN22 with JAK1, which blocks STAT3 phosphorylation, thereby limiting plasma cell differentiation.","method":"B cell-specific TRAF3-knockout mice; co-immunoprecipitation; phosphorylation assays; genetic rescue with IL-6 deletion","journal":"Science Signaling","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined molecular mechanism (PTPN22-JAK1 association), epistasis rescue, two orthogonal methods","pmids":["26329582"],"is_preprint":false},{"year":2016,"finding":"TRAF3 is a resident nuclear protein in B cells; the TRAF-C domain contains a functional nuclear localization signal; nuclear TRAF3 associates with transcriptional regulator CREB, reduces CREB stability (via decreased CREB ubiquitination), and inhibits CREB-mediated transcription including expression of the pro-survival protein Mcl-1.","method":"Cell fractionation; co-immunoprecipitation; TRAF-C domain deletion/mutagenesis; ubiquitination assay; luciferase reporter assay; B cell-specific TRAF3-knockout mice","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (fractionation, Co-IP, mutagenesis, reporter, genetic KO) in single study","pmids":["26755589"],"is_preprint":false},{"year":2018,"finding":"E3 ligase HECTD3 mediates K63-linked polyubiquitination of TRAF3 specifically at residue K138; this modification enables TRAF3-TBK1 complex formation and is required for type I IFN induction during intracellular bacterial infection. Both DOC and HECT domains of HECTD3 interact with TRAF3.","method":"Hectd3-knockout mice; ubiquitination assay with site-directed mutagenesis (K138); Co-immunoprecipitation; in vivo bacterial infection","journal":"The Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vivo genetic model, site-specific ubiquitination mutagenesis, complex formation assay, functional IFN readout","pmids":["29920190"],"is_preprint":false},{"year":2018,"finding":"TRAF3 forms a complex with TRAF2 and cIAP1 and mediates K48-linked ubiquitination and proteasomal degradation of ULK1; loss of ULK1 promotes inflammasome activation and pyroptosis in macrophages, linking TRAF3 to regulation of mitochondrial ROS and inflammatory cell death.","method":"Co-immunoprecipitation; ubiquitination assay; siRNA knockdown; inflammasome/caspase-1 activation assay","journal":"FASEB Journal","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus ubiquitination assay and functional pyroptosis readout, single lab","pmids":["32275117"],"is_preprint":false},{"year":2018,"finding":"TRAF3 promotes TCR signaling by associating with the TCR inhibitor Csk and promoting Csk dissociation from the plasma membrane, and by regulating localization of PTPN22; loss of TRAF3 increases membrane-associated Csk and PTPN22, decreasing activating phosphorylation of Lck.","method":"T cell-specific TRAF3-knockout mice; membrane fractionation; co-immunoprecipitation; Lck phosphorylation assay","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO, membrane fractionation with functional Lck phosphorylation readout, single lab","pmids":["28522807"],"is_preprint":false},{"year":2018,"finding":"Parkin E3 ubiquitin ligase interacts with TRAF3 and promotes Lys48-linked ubiquitination of TRAF3, targeting it for proteasomal degradation and thereby negatively regulating antiviral innate immune signaling.","method":"Co-immunoprecipitation; K48-linked ubiquitination assay; Parkin overexpression and knockout; virus infection assay","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus ubiquitination assay with genetic overexpression/knockout, single lab","pmids":["29903906"],"is_preprint":false},{"year":2018,"finding":"In the TRAF3-NIK module, TRAF3 positively regulates RNA pathway IFN induction but negatively regulates DNA pathway IFN induction; loss of TRAF3 stabilizes NIK, which then activates STING-dependent DNA sensing independently of alternative NF-κB components, requiring NIK autophosphorylation and oligomerization.","method":"TRAF3- and NIK-deficient cells; virus infection; STING signaling assays; NIK autophosphorylation/oligomerization analysis","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with orthogonal pathway readouts, single lab","pmids":["30018345"],"is_preprint":false},{"year":2019,"finding":"TRAF3IP3 accumulates on mitochondria upon virus infection and bridges MAVS and TRAF3, facilitating recruitment of TRAF3 to MAVS for TBK1-IRF3 activation; Traf3ip3-deficient mice show severely compromised IFN production and vulnerability to RNA virus infection.","method":"Traf3ip3-knockout mice; co-immunoprecipitation; mitochondrial localization; virus infection","journal":"The EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse model with defined molecular mechanism (MAVS-TRAF3 bridging), multiple methods","pmids":["31390091"],"is_preprint":false},{"year":2019,"finding":"TGFβ1 induces degradation of TRAF3 in mesenchymal progenitor cells via GSK-3β, reducing TRAF3 protein levels during aging; TRAF3 normally prevents β-catenin degradation in mesenchymal progenitors; deletion of TRAF3 in mesenchymal progenitors activates NF-κB RelA and RelB to promote RANKL expression, enhancing osteoclastogenesis.","method":"Conditional TRAF3-knockout mice in mesenchymal progenitors; GSK-3β inhibitor studies; β-catenin and ubiquitination assays; bone phenotyping","journal":"Nature Communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined molecular mechanism, multiple pathway readouts, single lab","pmids":["31243287"],"is_preprint":false},{"year":2020,"finding":"TRIM24 directly mediates K63-linked ubiquitination of TRAF3 at K429/K436 on mitochondria upon VSV infection; this modification enables TRAF3 association with MAVS and TBK1, activating downstream antiviral signaling; ablation of TRIM24 impairs IFN-I induction and sensitizes mice to VSV.","method":"TRIM24-knockout mice; ubiquitination assay with site-directed mutagenesis; Co-immunoprecipitation; mitochondrial fractionation; virus infection","journal":"The Journal of Experimental Medicine","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-specific ubiquitination mutagenesis, in vivo knockout, multiple orthogonal methods","pmids":["32324863"],"is_preprint":false},{"year":2020,"finding":"OTUD7B deubiquitinase directly binds TRAF3 (but not NIK) via its OTU domain and deubiquitinates TRAF3, inhibiting TRAF3 proteolysis, thereby preventing NIK accumulation and non-canonical NF-κB pathway activation; catalytic mutant OTUD7B (C194S/H358R) abolishes this activity.","method":"Co-immunoprecipitation; ubiquitination assay; OTU-domain catalytic mutant; shRNA knockdown/overexpression; in vivo lung cancer metastasis model","journal":"Journal of Experimental & Clinical Cancer Research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus catalytic mutagenesis and functional NF-κB readout, single lab","pmids":["33198776"],"is_preprint":false},{"year":2021,"finding":"E3 ligase Nedd4l catalyzes K29-linked ubiquitination of TRAF3 specifically at Cys56 and Cys124 (zinc-finger cysteines); this cysteine ubiquitination enhances association of TRAF3 with cIAP1/2 and HECTD3 and increases K48/K63-linked ubiquitination of TRAF3; Nedd4l deficiency impairs TRAF3-TBK1 binding, TBK1/IRF3 phosphorylation, and antiviral IFN production in vivo.","method":"Nedd4l-knockout mice; site-directed mutagenesis of Cys56/Cys124; K29-linked ubiquitination assay; Co-immunoprecipitation; virus infection","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vivo knockout, site-specific cysteine ubiquitination mutagenesis, multiple orthogonal methods","pmids":["33608556"],"is_preprint":false},{"year":2021,"finding":"EV-D68 protease 2Apro cleaves TRAF3 at the C-terminal region; a catalytic cysteine-to-alanine mutation (C107A) in 2Apro abolishes TRAF3 cleavage, and mutation of TRAF3-G462A confers resistance to 2Apro cleavage; this cleavage suppresses IRF3 activation and IFN-β production.","method":"Protease cleavage assay; site-directed mutagenesis; IRF3 activation assay; IFN-β reporter","journal":"Journal of Virology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro protease cleavage with mutagenesis, single lab, functional IFN readout","pmids":["33148796"],"is_preprint":false},{"year":2021,"finding":"USP11 deubiquitinase interacts with TRAF3 and stabilizes it by removing ubiquitin; increased TRAF3 stability promotes IKKβ/NF-κB pathway activation and pyroptosis in cardiomyocytes under ischemia-reperfusion injury.","method":"Co-immunoprecipitation; ubiquitination assay; siRNA knockdown; ischemia-reperfusion model","journal":"Balkan Medical Journal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP plus ubiquitination assay, single lab, single study","pmids":["37000116"],"is_preprint":false},{"year":2016,"finding":"Hepatocyte TRAF3 directly binds TAK1 and induces TAK1 ubiquitination and subsequent autophosphorylation, enhancing activation of IKKβ-NF-κB and MKK-JNK-IRS1(Ser307) signaling cascades while disrupting AKT-GSK3β/FOXO1 signaling; the TRAF3-TAK1 interaction and TAK1 ubiquitination are required for TRAF3-driven hepatic steatosis.","method":"Liver-specific TRAF3-knockout and transgenic overexpression mice; Co-immunoprecipitation; ubiquitination assay; TAK1 inhibitor rescue; high-fat diet model","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — two genetic models (KO and transgenic), Co-IP, ubiquitination assay, pharmacological rescue, multiple readouts","pmids":["26882989"],"is_preprint":false},{"year":2019,"finding":"TRAF3 interacts with MAVS and promotes STING-mediated TBK1 phosphorylation; TRAF3 is required for cGAS-STING activation in enterovirus A71 infection; EV-A71 protease 2Apro targets TRAF3 to suppress cGAS-STING signaling, and supplementation with TRAF3 rescues 2Apro-mediated suppression.","method":"Co-immunoprecipitation; overexpression/knockdown; TBK1 phosphorylation assay; rescue experiments with TRAF3 supplementation","journal":"Signal Transduction and Targeted Therapy","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP, functional TBK1 activation, rescue experiments, single lab","pmids":["36823147"],"is_preprint":false},{"year":2017,"finding":"NDR1 kinase interacts with TRAF3 and prevents TRAF3 binding to IL-17R, thereby promoting formation of the IL-17R-Act1-TRAF6 complex and downstream NF-κB/MAPK signaling; this competitive binding is independent of NDR1 kinase activity.","method":"Co-immunoprecipitation; competitive binding assay; NDR1-deficient mice; kinase-dead mutant; IL-17 signaling readouts","journal":"EMBO Reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — competitive Co-IP, kinase-dead mutant, knockout mouse model, single lab","pmids":["28219902"],"is_preprint":false},{"year":2023,"finding":"TRAF3 promotes STAT6 K450 ubiquitination and transcriptional activity in macrophages; TRAF3 deficiency specifically reduces ubiquitination at STAT6 K450 and K129, abolishes IL-4-induced M2 macrophage polarization, and suppresses tumor growth in a melanoma mouse model.","method":"Quantitative ubiquitomics; ubiquitination assay; site-mutation analysis (K450, K129); luciferase reporter; myeloid TRAF3-knockout mice","journal":"Cell Death and Differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-specific ubiquitination mutagenesis, quantitative proteomics, in vivo tumor model, single lab","pmids":["37474750"],"is_preprint":false},{"year":2021,"finding":"TRAF3 interacts with MFF (Mitochondrial Fission Factor) in B lymphocytes; in resting B cells deprived of survival factors, TRAF3 is mobilized to mitochondria through MFF interaction, where it triggers mitochondria-dependent apoptosis; TRAF3 co-expression with MFF decreases phosphorylation and ubiquitination of MFF.","method":"Co-immunoprecipitation; GST pull-down; mitochondrial fractionation/localization; TRAF3-deficient B cells; mitochondrial function assays","journal":"Frontiers in Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and pull-down, mitochondrial fractionation, genetic KO with defined apoptotic phenotype, single lab","pmids":["34745083"],"is_preprint":false},{"year":2025,"finding":"TRAF3 interacts with ECH1 (enoyl-CoA hydratase 1) and mediates K63-linked ubiquitination of ECH1 at Lys214; this ubiquitination impedes TOMM20-dependent mitochondrial translocation of ECH1, which otherwise promotes oxidation of polyunsaturated fatty acids and limits lipid peroxidation; TRAF3 loss in GBM thus enhances FAO and protects against ferroptosis.","method":"Co-immunoprecipitation; K63-linked ubiquitination assay; site-directed mutagenesis (K214); mitochondrial import assay; TRAF3-overexpression in GBM mouse models; ferroptosis assay","journal":"The Journal of Clinical Investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, site-specific ubiquitination, mitochondrial import, in vivo tumor model, single lab","pmids":["39932808"],"is_preprint":false},{"year":2007,"finding":"Crystal structures of the TRAF3 TRAF domain in complex with binding partners (CD40, LTβR, BAFF-R, TANK, and EBV LMP1) reveal that all recognition motifs are accommodated within a single hydrophobic crevice on TRAF3, and that this binding interface is structurally adaptive.","method":"X-ray crystallography of five distinct TRAF3 complexes","journal":"Advances in Experimental Medicine and Biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple crystal structures of the same binding crevice with five different partners","pmids":["17633021"],"is_preprint":false},{"year":2006,"finding":"CD40 mediates apoptosis in carcinoma cells through rapid post-translational upregulation of TRAF3 protein (without change in mRNA), followed by JNK/AP-1 pathway activation and caspase-9/caspase-3-dependent intrinsic apoptosis; TRAF3 knockdown abrogates JNK/AP-1 activation and CD40-mediated apoptosis.","method":"TRAF3 siRNA knockdown; JNK/AP-1 activation assays; caspase activity assays; CD40 re-expression in CD40-negative cells","journal":"Cell Death and Differentiation","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — siRNA knockdown with functional signaling and apoptosis readouts, single lab","pmids":["16429118"],"is_preprint":false},{"year":2009,"finding":"TRAF2 and TRAF3 each independently mediate immunoglobulin class switch recombination driven by CD40; mice expressing CD40 that selectively lacks binding to both TRAF2 and TRAF3 lose virtually all CD40-driven CSR, germinal center formation, and non-canonical NF-κB activation.","method":"Genetic epistasis using CD40 binding-site mutant transgenes in CD40-knockout mice; CSR assays; NF-κB activation measurement","journal":"International Immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis with selective binding-site mutations, multiple functional readouts","pmids":["19228877"],"is_preprint":false},{"year":2015,"finding":"TRAF3 limits RANKL-induced osteoclast formation by promoting proteasomal degradation of NIK in a complex with TRAF2 and cIAP proteins in osteoclast precursors; chloroquine prevents TRAF3 degradation in osteoclast precursors and inhibits osteoclast formation in vitro and bone destruction in vivo.","method":"Conditional TRAF3-knockout mice; NIK stability assays; chloroquine treatment in vitro and in vivo (ovariectomy/PTH models)","journal":"Frontiers in Immunology (review with primary data citations)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO model with defined NIK mechanism, pharmacological rescue, multiple in vivo models","pmids":["30323820"],"is_preprint":false}],"current_model":"TRAF3 is a multifunctional intracellular adaptor/E3 ubiquitin ligase that (1) positively regulates type I interferon production by bridging TLR/RLR adaptors (TRIF, MAVS/Cardif) to downstream kinases TBK1/IKK-ε via direct protein interactions and K63-linked auto- or trans-ubiquitination (catalyzed by HECTD3, TRIM24, and Nedd4l); (2) negatively regulates non-canonical NF-κB signaling by maintaining NIK in a degradation complex with TRAF2 and cIAP1/2, such that receptor activation causes TRAF2-dependent K48-ubiquitination and proteasomal destruction of TRAF3, releasing NIK; (3) acts as a resident nuclear protein in B cells where its TRAF-C domain inhibits CREB stability and transcription; (4) binds TAK1 to promote its ubiquitination and autophosphorylation in hepatocytes; (5) mediates ubiquitination of additional substrates (ULK1, ECH1, STAT6, MFF) to regulate autophagy, lipid metabolism, macrophage polarization, and mitochondria-dependent apoptosis; and (6) is itself regulated by deubiquitinases (OTUB1/2, OTUD7B, USP11), stabilizing factors (iOPN), and proteolytic cleavage by viral proteases (EV-D68 2Apro)."},"narrative":{"mechanistic_narrative":"TRAF3 is a multifunctional intracellular adaptor and ubiquitin-pathway hub that couples TNF-receptor-superfamily and innate immune receptors to opposing transcriptional outputs, first identified as a direct CD40 cytoplasmic-tail binding partner whose TRAF-C domain mediates receptor binding and homodimerization [PMID:7533327]. Structurally, a single adaptive hydrophobic crevice in the TRAF domain accommodates diverse partners including CD40, LTβR, BAFF-R, TANK and viral LMP1, explaining how one surface integrates many receptor inputs [PMID:17633021]. In innate antiviral signaling, TRAF3 is a positive regulator of type I interferon induction, bridging TLR adaptors (MyD88, TRIF, IRAK1) and the RLR adaptor MAVS/Cardif to the IRF3/7 kinases TBK1 and IKK-ε; TRAF-domain point mutations that abolish MAVS binding also abolish IFN production [PMID:16306937, PMID:16306936, PMID:16858409]. This bridging function depends on activating K63-linked ubiquitination of TRAF3 catalyzed by HECTD3 (at K138), TRIM24 (at K429/K436), and Nedd4l (cysteine ubiquitination at Cys56/Cys124 that licenses further K48/K63 modification and TBK1 binding), each enabling TRAF3-TBK1 complex assembly on mitochondria [PMID:29920190, PMID:32324863, PMID:33608556]. In a counterbalancing role, TRAF3 is a critical negative regulator of non-canonical NF-κB signaling: it maintains NIK in a degradation-competent complex with TRAF2 and cIAP1/2, and receptor engagement triggers cIAP-mediated K48-ubiquitination and proteasomal destruction of TRAF3 — a step requiring the RING domain of TRAF2 — which releases and stabilizes NIK to drive p100 processing [PMID:17015635, PMID:18997792, PMID:20348096, PMID:20185819]. TRAF3 abundance is tuned by deubiquitinases that stabilize it (OTUB1/2, OTUD7B, USP11) and by stabilizing or destabilizing factors (iOPN, Parkin, Triad3A) [PMID:19996094, PMID:27026194, PMID:29903906, PMID:33198776]. Beyond these core axes, TRAF3 acts as a resident nuclear protein in B cells, where its TRAF-C-domain NLS targets it to associate with and destabilize CREB, repressing CREB-driven transcription including Mcl-1 [PMID:26755589], and it ubiquitinates substrates including TAK1, STAT6, ULK1, ECH1 and MFF to control hepatic metabolism, macrophage polarization, inflammasome-driven cell death, ferroptosis, and mitochondrial apoptosis [PMID:26882989, PMID:37474750, PMID:32275117, PMID:39932808, PMID:34745083].","teleology":[{"year":1995,"claim":"Established TRAF3 as a direct receptor adaptor by identifying it as a CD40 cytoplasmic-tail binding protein and mapping the binding determinant.","evidence":"Yeast two-hybrid screen plus domain-deletion mapping defining the TRAF-C domain","pmids":["7533327"],"confidence":"High","gaps":["Did not define downstream signaling consequences of the interaction","No structural detail of the binding interface"]},{"year":2005,"claim":"Defined TRAF3 as a non-redundant positive node for type I IFN and IL-10 induction, linking TLR adaptors to the IRF kinases.","evidence":"Adaptor-complex isolation and TRAF3-deficient myeloid cells/fibroblasts with cytokine and virus-infection readouts","pmids":["16306937","16306936"],"confidence":"High","gaps":["Mechanism of TBK1 recruitment by TRAF3 not resolved at molecular level","Did not address how TRAF3 distinguishes IFN from pro-inflammatory output"]},{"year":2006,"claim":"Extended the antiviral role to RLR signaling by demonstrating a direct TRAF-domain–MAVS/Cardif interaction required for IFN production.","evidence":"In vitro binding plus TRAF-domain mutagenesis with IFN induction readout","pmids":["16858409"],"confidence":"High","gaps":["Did not establish ubiquitin requirement for the MAVS-coupled function","Recruitment to mitochondria not addressed"]},{"year":2006,"claim":"Genetically established TRAF3 as the critical brake on non-canonical NF-κB by showing NIK accumulation upon TRAF3 loss and rescue of lethality by p100 deletion.","evidence":"TRAF3-/-;p100-/- double-knockout epistasis, NIK Western blotting, B cell phenotyping","pmids":["17015635"],"confidence":"High","gaps":["Did not define the biochemical mechanism of NIK turnover","Roles of TRAF2/cIAP not yet incorporated"]},{"year":2008,"claim":"Resolved the NIK-control mechanism: TRAF3 is degraded by a TRAF2-cIAP1/2 complex upon receptor engagement, releasing NIK.","evidence":"Ubiquitination assays, cIAP1/2 and TRAF2 knockouts, receptor stimulation, proteasome inhibition","pmids":["18997792"],"confidence":"High","gaps":["Did not resolve which RING domain catalyzes the modification","Receptor-specific kinetics not fully mapped"]},{"year":2010,"claim":"Clarified receptor competition and ligase assignment: LTβR and NIK share a TRAF3 recognition crevice, and stimulus-dependent TRAF3 degradation requires the TRAF2 RING, not TRAF3's own.","evidence":"Charge-repulsion crevice mutagenesis, Co-IP, ubiquitination and proteasome-inhibitor studies; siRNA depletion for dual canonical/non-canonical regulation","pmids":["20348096","20185819"],"confidence":"High","gaps":["Medium-confidence dual-pathway claim rests on single-lab siRNA work","Quantitative competition kinetics between NIK and receptor not defined"]},{"year":2007,"claim":"Provided the structural basis for TRAF3's promiscuous receptor binding via a single adaptive crevice.","evidence":"X-ray crystallography of five TRAF3 TRAF-domain complexes (CD40, LTβR, BAFF-R, TANK, LMP1)","pmids":["17633021"],"confidence":"High","gaps":["Structures do not capture the ubiquitin-ligase or NIK-degradation complex","Conformational changes during signaling not visualized"]},{"year":2016,"claim":"Identified a nuclear function: TRAF3's TRAF-C NLS directs it to destabilize CREB and repress pro-survival transcription in B cells.","evidence":"Fractionation, Co-IP, TRAF-C mutagenesis, ubiquitination and reporter assays in B cell–specific knockouts","pmids":["26755589"],"confidence":"High","gaps":["Mechanism by which TRAF3 reduces CREB ubiquitination/stability not fully defined","Nuclear vs cytoplasmic partitioning signals not mapped"]},{"year":2016,"claim":"Connected TRAF3 to hepatic metabolic disease by defining a TRAF3-TAK1 ubiquitination axis driving steatosis.","evidence":"Liver-specific knockout and transgenic mice, Co-IP, ubiquitination assay, TAK1-inhibitor rescue, high-fat-diet model","pmids":["26882989"],"confidence":"High","gaps":["Linkage type of TAK1 ubiquitination not specified","Tissue-selectivity of this axis vs immune cells unclear"]},{"year":2018,"claim":"Defined site-specific activating ubiquitination (HECTD3 at K138; TRIM24 at K429/K436) as the trigger for TRAF3-TBK1 complex formation in antibacterial/antiviral IFN responses.","evidence":"Hectd3- and Trim24-knockout mice, site-directed ubiquitination mutagenesis, Co-IP, infection models","pmids":["29920190","32324863"],"confidence":"High","gaps":["Hierarchy and interplay among multiple K63-ligases unresolved","Whether modifications are auto- or trans-catalyzed in vivo not fully settled"]},{"year":2021,"claim":"Revealed a priming layer of regulation in which Nedd4l-mediated K29-cysteine ubiquitination of TRAF3 zinc fingers licenses subsequent K48/K63 modification and TBK1 binding.","evidence":"Nedd4l-knockout mice, Cys56/Cys124 mutagenesis, K29-linkage ubiquitination assay, Co-IP, infection","pmids":["33608556"],"confidence":"High","gaps":["Order of cysteine vs lysine ubiquitination in vivo not resolved","Reader for K29 chains not identified"]},{"year":2019,"claim":"Identified mitochondrial bridging and STING crosstalk: TRAF3IP3 recruits TRAF3 to MAVS, and TRAF3 couples MAVS to STING-dependent TBK1 activation, while NIK release diverts DNA-sensing output.","evidence":"Traf3ip3-knockout mice, Co-IP, mitochondrial localization; TRAF3/NIK-deficient cells with STING and NIK oligomerization assays; EV-A71 rescue experiments","pmids":["31390091","30018345","36823147"],"confidence":"High","gaps":["Opposite RNA vs DNA pathway roles (Medium) from single lab","Spatial coordination of MAVS- and STING-coupled pools unclear"]},{"year":2023,"claim":"Expanded the substrate repertoire to non-immune-receptor targets controlling cell fate and metabolism (STAT6, ULK1, ECH1, MFF).","evidence":"Site-specific ubiquitination mutagenesis, ubiquitomics, mitochondrial import assays, conditional knockouts and tumor/apoptosis models","pmids":["37474750","32275117","39932808","34745083"],"confidence":"Medium","gaps":["Each substrate validated by a single lab","Whether these activities require the canonical TRAF2/cIAP complex not uniformly tested"]},{"year":2021,"claim":"Mapped the deubiquitinase counter-regulation that sets TRAF3 abundance and downstream pathway tone (OTUB1/2, OTUD7B, USP11; stabilizers iOPN; destabilizers Parkin/Triad3A).","evidence":"Co-IP, ubiquitination assays, catalytic-mutant and knockdown/knockout studies in viral, cancer, and ischemia models","pmids":["19996094","33198776","37000116","27026194","29903906"],"confidence":"Medium","gaps":["USP11 cardiomyocyte axis is Low-confidence single study","Linkage specificity removed by each DUB not uniformly defined"]},{"year":2009,"claim":"Demonstrated physiological B-cell requirement for TRAF2/TRAF3 in CD40-driven class switch recombination and germinal center formation.","evidence":"CD40 binding-site mutant transgenes in CD40-knockout mice with CSR and NF-κB readouts","pmids":["19228877"],"confidence":"High","gaps":["Does not separate adaptor vs ligase contributions of TRAF3","Mechanistic coupling to CSR machinery unaddressed"]},{"year":null,"claim":"How TRAF3 dynamically partitions among its opposing roles — antiviral IFN amplifier, non-canonical NF-κB brake, nuclear CREB repressor, and mitochondrial death/metabolism regulator — within a single cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of how ubiquitin-linkage choice routes TRAF3 to distinct fates","Spatial/temporal switch between cytosolic, mitochondrial, and nuclear pools uncharacterized","Hierarchy among the many competing E3 ligases and DUBs in vivo not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[5,13,20,22,25,28,30]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[5,13,20,22]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,3,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,5,8]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[12]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[12]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[18,20,29,30]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,5]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,2,3,4,5,13,20,22,33]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5,7,8,17,25,27]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[5,13,20,22,28,30]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14,29,32]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[12]}],"complexes":["TRAF3-TRAF2-cIAP1/2-NIK degradation complex","TRAF3-TBK1 antiviral signaling complex","MAVS-TRAF3IP3-TRAF3 mitochondrial complex"],"partners":["CD40","MAVS","TRAF2","TBK1","NIK","TAK1","STAT6","MFF"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13114","full_name":"TNF receptor-associated factor 3","aliases":["CD40 receptor-associated factor 1","CRAF1","CD40-binding protein","CD40BP","LMP1-associated protein 1","LAP1","RING-type E3 ubiquitin transferase TRAF3"],"length_aa":568,"mass_kda":64.5,"function":"Cytoplasmic E3 ubiquitin ligase that regulates various signaling pathways, such as the NF-kappa-B, mitogen-activated protein kinase (MAPK) and interferon regulatory factor (IRF) pathways, and thus controls a lot of biological processes in both immune and non-immune cell types (PubMed:33148796, PubMed:33608556). In TLR and RLR signaling pathways, acts as an E3 ubiquitin ligase promoting the synthesis of 'Lys-63'-linked polyubiquitin chains on several substrates such as ASC that lead to the activation of the type I interferon response or the inflammasome (PubMed:25847972, PubMed:27980081). Following the activation of certain TLRs such as TLR4, acts as a negative NF-kappa-B regulator, possibly to avoid unregulated inflammatory response, and its degradation via 'Lys-48'-linked polyubiquitination is required for MAPK activation and production of inflammatory cytokines. Alternatively, when TLR4 orchestrates bacterial expulsion, TRAF3 undergoes 'Lys-33'-linked polyubiquitination and subsequently binds to RALGDS, mobilizing the exocyst complex to rapidly expel intracellular bacteria back for clearance (PubMed:27438768). Also acts as a constitutive negative regulator of the alternative NF-kappa-B pathway, which controls B-cell survival and lymphoid organ development. Required for normal antibody isotype switching from IgM to IgG. Plays a role T-cell dependent immune responses. Down-regulates proteolytic processing of NFKB2, and thereby inhibits non-canonical activation of NF-kappa-B. Promotes ubiquitination and proteasomal degradation of MAP3K14","subcellular_location":"Cytoplasm; Endosome; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q13114/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TRAF3","classification":"Not Classified","n_dependent_lines":36,"n_total_lines":1208,"dependency_fraction":0.029801324503311258},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"EWSR1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TRAF3","total_profiled":1310},"omim":[{"mim_id":"621096","title":"IMMUNODEFICIENCY 132B; IMD132B","url":"https://www.omim.org/entry/621096"},{"mim_id":"620004","title":"NMRA-LIKE REDOX SENSOR 1; NMRAL1","url":"https://www.omim.org/entry/620004"},{"mim_id":"619906","title":"DExD-BOX HELICASE 39A; DDX39A","url":"https://www.omim.org/entry/619906"},{"mim_id":"618638","title":"HECT DOMAIN E3 UBIQUITIN PROTEIN LIGASE 3; HECTD3","url":"https://www.omim.org/entry/618638"},{"mim_id":"617178","title":"RING FINGER PROTEIN 166; RNF166","url":"https://www.omim.org/entry/617178"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TRAF3"},"hgnc":{"alias_symbol":["CAP-1","CD40bp","CRAF1","LAP1","RNF118"],"prev_symbol":[]},"alphafold":{"accession":"Q13114","domains":[{"cath_id":"3.30.40.10","chopping":"50-142","consensus_level":"high","plddt":95.0434,"start":50,"end":142},{"cath_id":"2.60.210.10","chopping":"412-561","consensus_level":"high","plddt":94.4716,"start":412,"end":561},{"cath_id":"1.20.5","chopping":"252-348","consensus_level":"medium","plddt":93.1366,"start":252,"end":348}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13114","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13114-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13114-F1-predicted_aligned_error_v6.png","plddt_mean":87.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TRAF3","jax_strain_url":"https://www.jax.org/strain/search?query=TRAF3"},"sequence":{"accession":"Q13114","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13114.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13114/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13114"}},"corpus_meta":[{"pmid":"16306937","id":"PMC_16306937","title":"Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16306937","citation_count":755,"is_preprint":false},{"pmid":"16306936","id":"PMC_16306936","title":"Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16306936","citation_count":701,"is_preprint":false},{"pmid":"18997792","id":"PMC_18997792","title":"Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.","date":"2008","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18997792","citation_count":524,"is_preprint":false},{"pmid":"7533327","id":"PMC_7533327","title":"Involvement of CRAF1, a relative of TRAF, in CD40 signaling.","date":"1995","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/7533327","citation_count":439,"is_preprint":false},{"pmid":"21660053","id":"PMC_21660053","title":"Expanding TRAF function: TRAF3 as a tri-faced immune regulator.","date":"2011","source":"Nature reviews. Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21660053","citation_count":395,"is_preprint":false},{"pmid":"16858409","id":"PMC_16858409","title":"Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16858409","citation_count":349,"is_preprint":false},{"pmid":"11296228","id":"PMC_11296228","title":"Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11296228","citation_count":257,"is_preprint":false},{"pmid":"2188091","id":"PMC_2188091","title":"Mutational activation of c-raf-1 and definition of the minimal transforming sequence.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2188091","citation_count":241,"is_preprint":false},{"pmid":"33524237","id":"PMC_33524237","title":"Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap® Analog by In Vitro Transcription.","date":"2021","source":"Current protocols","url":"https://pubmed.ncbi.nlm.nih.gov/33524237","citation_count":175,"is_preprint":false},{"pmid":"10698440","id":"PMC_10698440","title":"The discovery of potent cRaf1 kinase inhibitors.","date":"2000","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/10698440","citation_count":172,"is_preprint":false},{"pmid":"15467832","id":"PMC_15467832","title":"Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis.","date":"2004","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15467832","citation_count":161,"is_preprint":false},{"pmid":"19996094","id":"PMC_19996094","title":"Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19996094","citation_count":161,"is_preprint":false},{"pmid":"9151858","id":"PMC_9151858","title":"Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.","date":"1997","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9151858","citation_count":146,"is_preprint":false},{"pmid":"17015635","id":"PMC_17015635","title":"Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.","date":"2006","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17015635","citation_count":143,"is_preprint":false},{"pmid":"26882989","id":"PMC_26882989","title":"Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26882989","citation_count":114,"is_preprint":false},{"pmid":"33406428","id":"PMC_33406428","title":"Expression of miRNA-29 in Pancreatic β Cells Promotes Inflammation and Diabetes via TRAF3.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33406428","citation_count":109,"is_preprint":false},{"pmid":"33608556","id":"PMC_33608556","title":"E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33608556","citation_count":97,"is_preprint":false},{"pmid":"22017431","id":"PMC_22017431","title":"Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.","date":"2011","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22017431","citation_count":90,"is_preprint":false},{"pmid":"26334576","id":"PMC_26334576","title":"Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.","date":"2015","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/26334576","citation_count":88,"is_preprint":false},{"pmid":"31243287","id":"PMC_31243287","title":"TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31243287","citation_count":79,"is_preprint":false},{"pmid":"8108400","id":"PMC_8108400","title":"Enzymatic characteristics of the c-Raf-1 protein kinase.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8108400","citation_count":77,"is_preprint":false},{"pmid":"25468570","id":"PMC_25468570","title":"Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25468570","citation_count":73,"is_preprint":false},{"pmid":"22469134","id":"PMC_22469134","title":"Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma.","date":"2012","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/22469134","citation_count":73,"is_preprint":false},{"pmid":"20185819","id":"PMC_20185819","title":"TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20185819","citation_count":71,"is_preprint":false},{"pmid":"37474750","id":"PMC_37474750","title":"TRAF3/STAT6 axis regulates macrophage polarization and tumor progression.","date":"2023","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/37474750","citation_count":70,"is_preprint":false},{"pmid":"24378539","id":"PMC_24378539","title":"TRAF3 regulates the effector function of regulatory T cells and humoral immune responses.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24378539","citation_count":69,"is_preprint":false},{"pmid":"33148417","id":"PMC_33148417","title":"Downregulation of circular RNA HECTD1 induces neuroprotection against ischemic stroke through the microRNA-133b/TRAF3 pathway.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33148417","citation_count":66,"is_preprint":false},{"pmid":"20348096","id":"PMC_20348096","title":"Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20348096","citation_count":65,"is_preprint":false},{"pmid":"16311516","id":"PMC_16311516","title":"The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling.","date":"2006","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/16311516","citation_count":65,"is_preprint":false},{"pmid":"25422508","id":"PMC_25422508","title":"Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25422508","citation_count":64,"is_preprint":false},{"pmid":"32802180","id":"PMC_32802180","title":"Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32802180","citation_count":63,"is_preprint":false},{"pmid":"16429118","id":"PMC_16429118","title":"A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation.","date":"2006","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16429118","citation_count":63,"is_preprint":false},{"pmid":"30323820","id":"PMC_30323820","title":"Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30323820","citation_count":62,"is_preprint":false},{"pmid":"17633016","id":"PMC_17633016","title":"TRAF3 and its biological function.","date":"2007","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/17633016","citation_count":57,"is_preprint":false},{"pmid":"30319624","id":"PMC_30319624","title":"TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30319624","citation_count":55,"is_preprint":false},{"pmid":"29920190","id":"PMC_29920190","title":"HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29920190","citation_count":53,"is_preprint":false},{"pmid":"32324863","id":"PMC_32324863","title":"TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32324863","citation_count":51,"is_preprint":false},{"pmid":"8451761","id":"PMC_8451761","title":"Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors.","date":"1993","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/8451761","citation_count":51,"is_preprint":false},{"pmid":"32412239","id":"PMC_32412239","title":"Novel Pathway for Chloramphenicol Catabolism in the Activated Sludge Bacterial Isolate Sphingobium sp. CAP-1.","date":"2020","source":"Environmental science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/32412239","citation_count":50,"is_preprint":false},{"pmid":"31390091","id":"PMC_31390091","title":"TRAF3IP3 mediates the recruitment of TRAF3 to MAVS for antiviral innate immunity.","date":"2019","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/31390091","citation_count":46,"is_preprint":false},{"pmid":"25072696","id":"PMC_25072696","title":"NEDD4 ubiquitinates TRAF3 to promote CD40-mediated AKT activation.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25072696","citation_count":46,"is_preprint":false},{"pmid":"27752131","id":"PMC_27752131","title":"TRAF3 deficiency promotes metabolic reprogramming in B cells.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27752131","citation_count":45,"is_preprint":false},{"pmid":"28219902","id":"PMC_28219902","title":"NDR1 protein kinase promotes IL-17- and TNF-α-mediated inflammation by competitively binding TRAF3.","date":"2017","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/28219902","citation_count":43,"is_preprint":false},{"pmid":"35546649","id":"PMC_35546649","title":"Mesenchymal Stem Cell-Derived Exosome-Loaded microRNA-129-5p Inhibits TRAF3 Expression to Alleviate Apoptosis and Oxidative Stress in Heart Failure.","date":"2022","source":"Cardiovascular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35546649","citation_count":43,"is_preprint":false},{"pmid":"26755589","id":"PMC_26755589","title":"Nuclear TRAF3 is a negative regulator of CREB in B cells.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26755589","citation_count":42,"is_preprint":false},{"pmid":"26329582","id":"PMC_26329582","title":"The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.","date":"2015","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/26329582","citation_count":42,"is_preprint":false},{"pmid":"11865188","id":"PMC_11865188","title":"Tangled webs: evidence of cross-talk between c-Raf-1 and Akt.","date":"1999","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/11865188","citation_count":40,"is_preprint":false},{"pmid":"36845015","id":"PMC_36845015","title":"The Roles of TRAF3 in Immune Responses.","date":"2023","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/36845015","citation_count":39,"is_preprint":false},{"pmid":"32275117","id":"PMC_32275117","title":"TRAF3 promotes ROS production and pyroptosis by targeting ULK1 ubiquitination in macrophages.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32275117","citation_count":39,"is_preprint":false},{"pmid":"39406701","id":"PMC_39406701","title":"Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα-TRAF3-TAK1-MAPK axis.","date":"2024","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39406701","citation_count":37,"is_preprint":false},{"pmid":"33198776","id":"PMC_33198776","title":"OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3.","date":"2020","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/33198776","citation_count":37,"is_preprint":false},{"pmid":"27026194","id":"PMC_27026194","title":"Intracellular osteopontin stabilizes TRAF3 to positively regulate innate antiviral response.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27026194","citation_count":37,"is_preprint":false},{"pmid":"30018345","id":"PMC_30018345","title":"A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30018345","citation_count":36,"is_preprint":false},{"pmid":"24433987","id":"PMC_24433987","title":"Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.","date":"2013","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/24433987","citation_count":35,"is_preprint":false},{"pmid":"25628422","id":"PMC_25628422","title":"Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity.","date":"2015","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25628422","citation_count":35,"is_preprint":false},{"pmid":"10860842","id":"PMC_10860842","title":"Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10860842","citation_count":35,"is_preprint":false},{"pmid":"26085206","id":"PMC_26085206","title":"TRAF3, ubiquitination, and B-lymphocyte regulation.","date":"2015","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26085206","citation_count":34,"is_preprint":false},{"pmid":"36693922","id":"PMC_36693922","title":"FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes.","date":"2023","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36693922","citation_count":33,"is_preprint":false},{"pmid":"17917053","id":"PMC_17917053","title":"Multiple roles of TRAF3 signaling in lymphocyte function.","date":"2007","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/17917053","citation_count":33,"is_preprint":false},{"pmid":"35960817","id":"PMC_35960817","title":"Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations.","date":"2022","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35960817","citation_count":32,"is_preprint":false},{"pmid":"27154354","id":"PMC_27154354","title":"TRAF3 as a powerful and multitalented regulator of lymphocyte functions.","date":"2016","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/27154354","citation_count":31,"is_preprint":false},{"pmid":"27208423","id":"PMC_27208423","title":"TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/27208423","citation_count":30,"is_preprint":false},{"pmid":"28522807","id":"PMC_28522807","title":"TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28522807","citation_count":30,"is_preprint":false},{"pmid":"33061854","id":"PMC_33061854","title":"MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferation.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33061854","citation_count":30,"is_preprint":false},{"pmid":"33627626","id":"PMC_33627626","title":"Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemia-reperfusion injury.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33627626","citation_count":30,"is_preprint":false},{"pmid":"33151563","id":"PMC_33151563","title":"Methionine selenium antagonizes LPS-induced necroptosis in the chicken liver via the miR-155/TRAF3/MAPK axis.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33151563","citation_count":30,"is_preprint":false},{"pmid":"26661944","id":"PMC_26661944","title":"TRAF3: a novel tumor suppressor gene in macrophages.","date":"2015","source":"Macrophage","url":"https://pubmed.ncbi.nlm.nih.gov/26661944","citation_count":29,"is_preprint":false},{"pmid":"36823147","id":"PMC_36823147","title":"TRAF3 activates STING-mediated suppression of EV-A71 and target of viral evasion.","date":"2023","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36823147","citation_count":28,"is_preprint":false},{"pmid":"33148796","id":"PMC_33148796","title":"Enterovirus D68 Protease 2Apro Targets TRAF3 To Subvert Host Innate Immune Responses.","date":"2021","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/33148796","citation_count":27,"is_preprint":false},{"pmid":"30682386","id":"PMC_30682386","title":"Various exercise intensities differentially regulate GAP-43 and CAP-1 expression in the rat hippocampus.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30682386","citation_count":26,"is_preprint":false},{"pmid":"25960828","id":"PMC_25960828","title":"Targeting TRAF3 Downstream Signaling Pathways in B cell Neoplasms.","date":"2015","source":"Journal of cancer science & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25960828","citation_count":24,"is_preprint":false},{"pmid":"32591397","id":"PMC_32591397","title":"TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy.","date":"2020","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/32591397","citation_count":23,"is_preprint":false},{"pmid":"29693188","id":"PMC_29693188","title":"RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NF‑κB and p38 signaling pathways.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29693188","citation_count":23,"is_preprint":false},{"pmid":"23329887","id":"PMC_23329887","title":"Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.","date":"2013","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23329887","citation_count":22,"is_preprint":false},{"pmid":"35091545","id":"PMC_35091545","title":"TRK-fused gene (TFG) regulates ULK1 stability via TRAF3-mediated ubiquitination and protects macrophages from LPS-induced pyroptosis.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35091545","citation_count":21,"is_preprint":false},{"pmid":"30622699","id":"PMC_30622699","title":"Cell type-specific function of TRAF2 and TRAF3 in regulating type I IFN induction.","date":"2019","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/30622699","citation_count":21,"is_preprint":false},{"pmid":"10488105","id":"PMC_10488105","title":"Activation of c-Raf-1 kinase signal transduction pathway in alpha(7) integrin-deficient mice.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10488105","citation_count":21,"is_preprint":false},{"pmid":"4008472","id":"PMC_4008472","title":"Activation of influenza virus-associated RNA polymerase by cap-1 structure (m7GpppNm).","date":"1985","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/4008472","citation_count":21,"is_preprint":false},{"pmid":"39932808","id":"PMC_39932808","title":"TRAF3 loss protects glioblastoma cells from lipid peroxidation and immune elimination via dysregulated lipid metabolism.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/39932808","citation_count":20,"is_preprint":false},{"pmid":"25723057","id":"PMC_25723057","title":"Roles of TRAF3 in T cells: many surprises.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25723057","citation_count":20,"is_preprint":false},{"pmid":"35413678","id":"PMC_35413678","title":"Circ_0050908 up-regulates TRAF3 by sponging miR-324-5p to aggravate myocardial ischemia-reperfusion injury.","date":"2022","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35413678","citation_count":20,"is_preprint":false},{"pmid":"31244811","id":"PMC_31244811","title":"TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins.","date":"2019","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31244811","citation_count":20,"is_preprint":false},{"pmid":"37000116","id":"PMC_37000116","title":"Ubiquitin-specific protease 11 Aggravates Ischemia-reperfusion-induced Cardiomyocyte Pyroptosis and Injury by Promoting TRAF3 Deubiquitination.","date":"2023","source":"Balkan medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/37000116","citation_count":20,"is_preprint":false},{"pmid":"33692778","id":"PMC_33692778","title":"Swine Acute Diarrhea Syndrome Coronavirus Nucleocapsid Protein Antagonizes Interferon-β Production via Blocking the Interaction Between TRAF3 and TBK1.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33692778","citation_count":20,"is_preprint":false},{"pmid":"25966214","id":"PMC_25966214","title":"Molecular cloning and expression analysis of TRAF3 in chicken.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/25966214","citation_count":19,"is_preprint":false},{"pmid":"32822908","id":"PMC_32822908","title":"MiR-92b-3p ameliorates inflammation and autophagy by targeting TRAF3 and suppressing MKK3-p38 pathway in caerulein-induced AR42J cells.","date":"2020","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32822908","citation_count":19,"is_preprint":false},{"pmid":"32829657","id":"PMC_32829657","title":"TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates Obesity-Associated Vascular Insulin Resistance and Dysfunction in Male Mice.","date":"2020","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/32829657","citation_count":18,"is_preprint":false},{"pmid":"25010048","id":"PMC_25010048","title":"TRAF3 regulates homeostasis of CD8+ central memory T cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25010048","citation_count":18,"is_preprint":false},{"pmid":"29903906","id":"PMC_29903906","title":"Parkin negatively regulates the antiviral signaling pathway by targeting TRAF3 for degradation.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29903906","citation_count":18,"is_preprint":false},{"pmid":"36752613","id":"PMC_36752613","title":"Heterogeneous Nuclear Protein U Degraded the m6A Methylated TRAF3 Transcript by YTHDF2 To Promote Porcine Epidemic Diarrhea Virus Replication.","date":"2023","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/36752613","citation_count":18,"is_preprint":false},{"pmid":"31501481","id":"PMC_31501481","title":"TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31501481","citation_count":17,"is_preprint":false},{"pmid":"36291141","id":"PMC_36291141","title":"TRAF3/p38-JNK Signalling Crosstalk with Intracellular-TRAIL/Caspase-10-Induced Apoptosis Accelerates ROS-Driven Cancer Cell-Specific Death by CD40.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36291141","citation_count":17,"is_preprint":false},{"pmid":"31826940","id":"PMC_31826940","title":"Elevated Choline Kinase α-Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31826940","citation_count":17,"is_preprint":false},{"pmid":"34745083","id":"PMC_34745083","title":"Mitochondrial Fission Factor Is a Novel Interacting Protein of the Critical B Cell Survival Regulator TRAF3 in B Lymphocytes.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34745083","citation_count":17,"is_preprint":false},{"pmid":"17633021","id":"PMC_17633021","title":"Protein-protein interactions in TRAF3.","date":"2007","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/17633021","citation_count":16,"is_preprint":false},{"pmid":"30687320","id":"PMC_30687320","title":"Dysregulated TRAF3 and BCL2 Expression Promotes Multiple Classes of Mature Non-hodgkin B Cell Lymphoma in Mice.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30687320","citation_count":16,"is_preprint":false},{"pmid":"30055802","id":"PMC_30055802","title":"Dihydromyricetin inhibits caerulin-induced TRAF3-p38 signaling activation and acute pancreatitis response.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30055802","citation_count":16,"is_preprint":false},{"pmid":"29553967","id":"PMC_29553967","title":"TRAF3-interacting protein 3, a new oncotarget, promotes tumor growth in melanoma.","date":"2018","source":"Melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/29553967","citation_count":15,"is_preprint":false},{"pmid":"12074572","id":"PMC_12074572","title":"Cell adhesion protects c-Raf-1 against ubiquitin-dependent degradation by the proteasome.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12074572","citation_count":15,"is_preprint":false},{"pmid":"19228877","id":"PMC_19228877","title":"TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40.","date":"2009","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19228877","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50379,"output_tokens":8575,"usd":0.139881,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18309,"output_tokens":5442,"usd":0.113797,"stage2_stop_reason":"end_turn"},"total_usd":0.253678,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"TRAF3 (then called CRAF1) was identified as a direct binding partner of the CD40 cytoplasmic tail; the TRAF-C domain of TRAF3 was necessary and sufficient for CD40 binding and homodimerization.\",\n      \"method\": \"Yeast two-hybrid screen; domain deletion analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid plus domain-deletion mapping, founding paper replicated widely\",\n      \"pmids\": [\"7533327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TRAF3 is recruited to TLR adaptor MyD88-containing signaling complexes and is essential for induction of type I interferons and IL-10 but dispensable for pro-inflammatory cytokines; TRAF3 is required to recruit TBK1 into TIR signaling complexes.\",\n      \"method\": \"Biochemical isolation of dimerized-adaptor signaling complexes; TRAF3-deficient myeloid cells from knockout mice; cytokine measurements\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal complex isolation, genetic knockout with defined cytokine phenotypes, replicated in companion paper\",\n      \"pmids\": [\"16306937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TRAF3 associates with TLR adaptors TRIF and IRAK1, as well as downstream IRF3/7 kinases TBK1 and IKK-ε, placing TRAF3 as a critical link between TLR adaptors and kinases required for IRF activation and type I IFN production; TRAF3-deficient fibroblasts are also defective in TLR-independent type I IFN responses to direct virus infection.\",\n      \"method\": \"Co-immunoprecipitation; TRAF3-deficient cells; virus infection assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, genetic KO with defined phenotypes, two independent pathways tested\",\n      \"pmids\": [\"16306936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TRAF3 directly interacts with the MAVS/Cardif adaptor through a TRAF-interaction motif (TIM) in Cardif and the TRAF domain of TRAF3; mutation of two critical amino acids in the TRAF domain abolishes both Cardif binding and TRAF3-dependent IFN production after viral infection.\",\n      \"method\": \"In vitro binding assays; site-directed mutagenesis of TRAF domain; IFN induction assays\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding reconstitution plus mutagenesis with functional IFN readout, single lab\",\n      \"pmids\": [\"16858409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Loss of TRAF3 results in constitutive non-canonical NF-κB activity and profound accumulation of NF-κB-inducing kinase (NIK) in TRAF3-deficient cells; the early postnatal lethality of TRAF3-knockout mice is rescued by compound loss of the non-canonical NF-κB p100 gene, genetically establishing TRAF3 as a critical negative modulator of the non-canonical NF-κB pathway.\",\n      \"method\": \"Genetic epistasis (TRAF3-/-;p100-/- double-knockout rescue); Western blotting for NIK; B cell phenotyping\",\n      \"journal\": \"The Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis (double-mutant rescue), multiple orthogonal readouts\",\n      \"pmids\": [\"17015635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TRAF3 is constitutively degraded in a TRAF2- and cIAP1/2-dependent manner; receptor (CD40 or BAFF-R) activation causes cIAP1/2-mediated K48-linked ubiquitination and proteasomal degradation of TRAF3, which releases NIK from the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, leading to NIK stabilization and NF-κB2-p100 processing.\",\n      \"method\": \"Ubiquitination assays; cIAP1/2 and TRAF2 knockouts; receptor stimulation experiments; proteasome inhibitor studies\",\n      \"journal\": \"Nature Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic tools, ubiquitination reconstitution, mechanistically defined E3 ligase activity, widely replicated\",\n      \"pmids\": [\"18997792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Deubiquitinating enzymes OTUB1 and OTUB2 interact with TRAF3, remove ubiquitin from TRAF3, and negatively regulate virus-triggered type I IFN induction; overexpression inhibits IRF3 and NF-κB activation while knockdown has the opposite effect.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assay; overexpression/knockdown; virus infection\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus functional ubiquitination assay, single lab, two orthogonal approaches\",\n      \"pmids\": [\"19996094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A charge-repulsion mutation in the receptor-binding crevice of TRAF3 ablated binding of both LTβR and NIK, suggesting they share a common recognition site; ligand-activated LTβR competitively displaces NIK from TRAF3, and recruited TRAF3/TRAF2 redirects ubiquitin ligase activity to polyubiquitinate TRAF3 and TRAF2 for proteasomal degradation; stimulus-dependent TRAF3 degradation required the RING domain of TRAF2 (not TRAF3).\",\n      \"method\": \"Site-directed mutagenesis; co-immunoprecipitation; ubiquitination assay; proteasome inhibitor studies\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with binding and ubiquitination reconstitution experiments, multiple orthogonal methods\",\n      \"pmids\": [\"20348096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAF3 negatively regulates both canonical and non-canonical NF-κB signaling by LTβR via two distinct mechanisms: by competitively blocking TRAF2 recruitment to the activated receptor (thereby inhibiting canonical IκBα phosphorylation) and by autonomously suppressing non-canonical NF-κB components (NIK, p100, RelB) independent of receptor stimulation.\",\n      \"method\": \"siRNA-mediated TRAF3 depletion; Western blotting; receptor-specific signaling assays; co-immunoprecipitation\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — siRNA plus immunoprecipitation, single lab, two orthogonal methods\",\n      \"pmids\": [\"20185819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NEDD4 E3 ubiquitin ligase constitutively interacts with CD40 and mediates K63-linked ubiquitination of TRAF3; this ubiquitination of TRAF3 by NEDD4 is critical for CD40-mediated AKT activation.\",\n      \"method\": \"Co-immunoprecipitation; K63-linked ubiquitination assay; AKT phosphorylation readout; genetic knockdown\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and ubiquitination assay, single lab, functional AKT readout\",\n      \"pmids\": [\"25072696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Intracellular osteopontin (iOPN) interacts with TRAF3 via its C-terminal fragment and inhibits Triad3A-mediated K48-linked polyubiquitination and degradation of TRAF3, thereby stabilizing TRAF3 and promoting antiviral type I IFN production.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assay; OPN-deficient mice; virus infection assay\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and ubiquitination assay with genetic knockout model, single lab\",\n      \"pmids\": [\"27026194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TRAF3 inhibits IL-6 receptor signaling in B cells by facilitating the association of phosphatase PTPN22 with JAK1, which blocks STAT3 phosphorylation, thereby limiting plasma cell differentiation.\",\n      \"method\": \"B cell-specific TRAF3-knockout mice; co-immunoprecipitation; phosphorylation assays; genetic rescue with IL-6 deletion\",\n      \"journal\": \"Science Signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined molecular mechanism (PTPN22-JAK1 association), epistasis rescue, two orthogonal methods\",\n      \"pmids\": [\"26329582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TRAF3 is a resident nuclear protein in B cells; the TRAF-C domain contains a functional nuclear localization signal; nuclear TRAF3 associates with transcriptional regulator CREB, reduces CREB stability (via decreased CREB ubiquitination), and inhibits CREB-mediated transcription including expression of the pro-survival protein Mcl-1.\",\n      \"method\": \"Cell fractionation; co-immunoprecipitation; TRAF-C domain deletion/mutagenesis; ubiquitination assay; luciferase reporter assay; B cell-specific TRAF3-knockout mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (fractionation, Co-IP, mutagenesis, reporter, genetic KO) in single study\",\n      \"pmids\": [\"26755589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"E3 ligase HECTD3 mediates K63-linked polyubiquitination of TRAF3 specifically at residue K138; this modification enables TRAF3-TBK1 complex formation and is required for type I IFN induction during intracellular bacterial infection. Both DOC and HECT domains of HECTD3 interact with TRAF3.\",\n      \"method\": \"Hectd3-knockout mice; ubiquitination assay with site-directed mutagenesis (K138); Co-immunoprecipitation; in vivo bacterial infection\",\n      \"journal\": \"The Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vivo genetic model, site-specific ubiquitination mutagenesis, complex formation assay, functional IFN readout\",\n      \"pmids\": [\"29920190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TRAF3 forms a complex with TRAF2 and cIAP1 and mediates K48-linked ubiquitination and proteasomal degradation of ULK1; loss of ULK1 promotes inflammasome activation and pyroptosis in macrophages, linking TRAF3 to regulation of mitochondrial ROS and inflammatory cell death.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assay; siRNA knockdown; inflammasome/caspase-1 activation assay\",\n      \"journal\": \"FASEB Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus ubiquitination assay and functional pyroptosis readout, single lab\",\n      \"pmids\": [\"32275117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TRAF3 promotes TCR signaling by associating with the TCR inhibitor Csk and promoting Csk dissociation from the plasma membrane, and by regulating localization of PTPN22; loss of TRAF3 increases membrane-associated Csk and PTPN22, decreasing activating phosphorylation of Lck.\",\n      \"method\": \"T cell-specific TRAF3-knockout mice; membrane fractionation; co-immunoprecipitation; Lck phosphorylation assay\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO, membrane fractionation with functional Lck phosphorylation readout, single lab\",\n      \"pmids\": [\"28522807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Parkin E3 ubiquitin ligase interacts with TRAF3 and promotes Lys48-linked ubiquitination of TRAF3, targeting it for proteasomal degradation and thereby negatively regulating antiviral innate immune signaling.\",\n      \"method\": \"Co-immunoprecipitation; K48-linked ubiquitination assay; Parkin overexpression and knockout; virus infection assay\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus ubiquitination assay with genetic overexpression/knockout, single lab\",\n      \"pmids\": [\"29903906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In the TRAF3-NIK module, TRAF3 positively regulates RNA pathway IFN induction but negatively regulates DNA pathway IFN induction; loss of TRAF3 stabilizes NIK, which then activates STING-dependent DNA sensing independently of alternative NF-κB components, requiring NIK autophosphorylation and oligomerization.\",\n      \"method\": \"TRAF3- and NIK-deficient cells; virus infection; STING signaling assays; NIK autophosphorylation/oligomerization analysis\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with orthogonal pathway readouts, single lab\",\n      \"pmids\": [\"30018345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TRAF3IP3 accumulates on mitochondria upon virus infection and bridges MAVS and TRAF3, facilitating recruitment of TRAF3 to MAVS for TBK1-IRF3 activation; Traf3ip3-deficient mice show severely compromised IFN production and vulnerability to RNA virus infection.\",\n      \"method\": \"Traf3ip3-knockout mice; co-immunoprecipitation; mitochondrial localization; virus infection\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse model with defined molecular mechanism (MAVS-TRAF3 bridging), multiple methods\",\n      \"pmids\": [\"31390091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TGFβ1 induces degradation of TRAF3 in mesenchymal progenitor cells via GSK-3β, reducing TRAF3 protein levels during aging; TRAF3 normally prevents β-catenin degradation in mesenchymal progenitors; deletion of TRAF3 in mesenchymal progenitors activates NF-κB RelA and RelB to promote RANKL expression, enhancing osteoclastogenesis.\",\n      \"method\": \"Conditional TRAF3-knockout mice in mesenchymal progenitors; GSK-3β inhibitor studies; β-catenin and ubiquitination assays; bone phenotyping\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined molecular mechanism, multiple pathway readouts, single lab\",\n      \"pmids\": [\"31243287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TRIM24 directly mediates K63-linked ubiquitination of TRAF3 at K429/K436 on mitochondria upon VSV infection; this modification enables TRAF3 association with MAVS and TBK1, activating downstream antiviral signaling; ablation of TRIM24 impairs IFN-I induction and sensitizes mice to VSV.\",\n      \"method\": \"TRIM24-knockout mice; ubiquitination assay with site-directed mutagenesis; Co-immunoprecipitation; mitochondrial fractionation; virus infection\",\n      \"journal\": \"The Journal of Experimental Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-specific ubiquitination mutagenesis, in vivo knockout, multiple orthogonal methods\",\n      \"pmids\": [\"32324863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"OTUD7B deubiquitinase directly binds TRAF3 (but not NIK) via its OTU domain and deubiquitinates TRAF3, inhibiting TRAF3 proteolysis, thereby preventing NIK accumulation and non-canonical NF-κB pathway activation; catalytic mutant OTUD7B (C194S/H358R) abolishes this activity.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assay; OTU-domain catalytic mutant; shRNA knockdown/overexpression; in vivo lung cancer metastasis model\",\n      \"journal\": \"Journal of Experimental & Clinical Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus catalytic mutagenesis and functional NF-κB readout, single lab\",\n      \"pmids\": [\"33198776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"E3 ligase Nedd4l catalyzes K29-linked ubiquitination of TRAF3 specifically at Cys56 and Cys124 (zinc-finger cysteines); this cysteine ubiquitination enhances association of TRAF3 with cIAP1/2 and HECTD3 and increases K48/K63-linked ubiquitination of TRAF3; Nedd4l deficiency impairs TRAF3-TBK1 binding, TBK1/IRF3 phosphorylation, and antiviral IFN production in vivo.\",\n      \"method\": \"Nedd4l-knockout mice; site-directed mutagenesis of Cys56/Cys124; K29-linked ubiquitination assay; Co-immunoprecipitation; virus infection\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vivo knockout, site-specific cysteine ubiquitination mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"33608556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EV-D68 protease 2Apro cleaves TRAF3 at the C-terminal region; a catalytic cysteine-to-alanine mutation (C107A) in 2Apro abolishes TRAF3 cleavage, and mutation of TRAF3-G462A confers resistance to 2Apro cleavage; this cleavage suppresses IRF3 activation and IFN-β production.\",\n      \"method\": \"Protease cleavage assay; site-directed mutagenesis; IRF3 activation assay; IFN-β reporter\",\n      \"journal\": \"Journal of Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro protease cleavage with mutagenesis, single lab, functional IFN readout\",\n      \"pmids\": [\"33148796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"USP11 deubiquitinase interacts with TRAF3 and stabilizes it by removing ubiquitin; increased TRAF3 stability promotes IKKβ/NF-κB pathway activation and pyroptosis in cardiomyocytes under ischemia-reperfusion injury.\",\n      \"method\": \"Co-immunoprecipitation; ubiquitination assay; siRNA knockdown; ischemia-reperfusion model\",\n      \"journal\": \"Balkan Medical Journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP plus ubiquitination assay, single lab, single study\",\n      \"pmids\": [\"37000116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hepatocyte TRAF3 directly binds TAK1 and induces TAK1 ubiquitination and subsequent autophosphorylation, enhancing activation of IKKβ-NF-κB and MKK-JNK-IRS1(Ser307) signaling cascades while disrupting AKT-GSK3β/FOXO1 signaling; the TRAF3-TAK1 interaction and TAK1 ubiquitination are required for TRAF3-driven hepatic steatosis.\",\n      \"method\": \"Liver-specific TRAF3-knockout and transgenic overexpression mice; Co-immunoprecipitation; ubiquitination assay; TAK1 inhibitor rescue; high-fat diet model\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two genetic models (KO and transgenic), Co-IP, ubiquitination assay, pharmacological rescue, multiple readouts\",\n      \"pmids\": [\"26882989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TRAF3 interacts with MAVS and promotes STING-mediated TBK1 phosphorylation; TRAF3 is required for cGAS-STING activation in enterovirus A71 infection; EV-A71 protease 2Apro targets TRAF3 to suppress cGAS-STING signaling, and supplementation with TRAF3 rescues 2Apro-mediated suppression.\",\n      \"method\": \"Co-immunoprecipitation; overexpression/knockdown; TBK1 phosphorylation assay; rescue experiments with TRAF3 supplementation\",\n      \"journal\": \"Signal Transduction and Targeted Therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP, functional TBK1 activation, rescue experiments, single lab\",\n      \"pmids\": [\"36823147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NDR1 kinase interacts with TRAF3 and prevents TRAF3 binding to IL-17R, thereby promoting formation of the IL-17R-Act1-TRAF6 complex and downstream NF-κB/MAPK signaling; this competitive binding is independent of NDR1 kinase activity.\",\n      \"method\": \"Co-immunoprecipitation; competitive binding assay; NDR1-deficient mice; kinase-dead mutant; IL-17 signaling readouts\",\n      \"journal\": \"EMBO Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — competitive Co-IP, kinase-dead mutant, knockout mouse model, single lab\",\n      \"pmids\": [\"28219902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TRAF3 promotes STAT6 K450 ubiquitination and transcriptional activity in macrophages; TRAF3 deficiency specifically reduces ubiquitination at STAT6 K450 and K129, abolishes IL-4-induced M2 macrophage polarization, and suppresses tumor growth in a melanoma mouse model.\",\n      \"method\": \"Quantitative ubiquitomics; ubiquitination assay; site-mutation analysis (K450, K129); luciferase reporter; myeloid TRAF3-knockout mice\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-specific ubiquitination mutagenesis, quantitative proteomics, in vivo tumor model, single lab\",\n      \"pmids\": [\"37474750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TRAF3 interacts with MFF (Mitochondrial Fission Factor) in B lymphocytes; in resting B cells deprived of survival factors, TRAF3 is mobilized to mitochondria through MFF interaction, where it triggers mitochondria-dependent apoptosis; TRAF3 co-expression with MFF decreases phosphorylation and ubiquitination of MFF.\",\n      \"method\": \"Co-immunoprecipitation; GST pull-down; mitochondrial fractionation/localization; TRAF3-deficient B cells; mitochondrial function assays\",\n      \"journal\": \"Frontiers in Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and pull-down, mitochondrial fractionation, genetic KO with defined apoptotic phenotype, single lab\",\n      \"pmids\": [\"34745083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TRAF3 interacts with ECH1 (enoyl-CoA hydratase 1) and mediates K63-linked ubiquitination of ECH1 at Lys214; this ubiquitination impedes TOMM20-dependent mitochondrial translocation of ECH1, which otherwise promotes oxidation of polyunsaturated fatty acids and limits lipid peroxidation; TRAF3 loss in GBM thus enhances FAO and protects against ferroptosis.\",\n      \"method\": \"Co-immunoprecipitation; K63-linked ubiquitination assay; site-directed mutagenesis (K214); mitochondrial import assay; TRAF3-overexpression in GBM mouse models; ferroptosis assay\",\n      \"journal\": \"The Journal of Clinical Investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, site-specific ubiquitination, mitochondrial import, in vivo tumor model, single lab\",\n      \"pmids\": [\"39932808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structures of the TRAF3 TRAF domain in complex with binding partners (CD40, LTβR, BAFF-R, TANK, and EBV LMP1) reveal that all recognition motifs are accommodated within a single hydrophobic crevice on TRAF3, and that this binding interface is structurally adaptive.\",\n      \"method\": \"X-ray crystallography of five distinct TRAF3 complexes\",\n      \"journal\": \"Advances in Experimental Medicine and Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple crystal structures of the same binding crevice with five different partners\",\n      \"pmids\": [\"17633021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CD40 mediates apoptosis in carcinoma cells through rapid post-translational upregulation of TRAF3 protein (without change in mRNA), followed by JNK/AP-1 pathway activation and caspase-9/caspase-3-dependent intrinsic apoptosis; TRAF3 knockdown abrogates JNK/AP-1 activation and CD40-mediated apoptosis.\",\n      \"method\": \"TRAF3 siRNA knockdown; JNK/AP-1 activation assays; caspase activity assays; CD40 re-expression in CD40-negative cells\",\n      \"journal\": \"Cell Death and Differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — siRNA knockdown with functional signaling and apoptosis readouts, single lab\",\n      \"pmids\": [\"16429118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TRAF2 and TRAF3 each independently mediate immunoglobulin class switch recombination driven by CD40; mice expressing CD40 that selectively lacks binding to both TRAF2 and TRAF3 lose virtually all CD40-driven CSR, germinal center formation, and non-canonical NF-κB activation.\",\n      \"method\": \"Genetic epistasis using CD40 binding-site mutant transgenes in CD40-knockout mice; CSR assays; NF-κB activation measurement\",\n      \"journal\": \"International Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis with selective binding-site mutations, multiple functional readouts\",\n      \"pmids\": [\"19228877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TRAF3 limits RANKL-induced osteoclast formation by promoting proteasomal degradation of NIK in a complex with TRAF2 and cIAP proteins in osteoclast precursors; chloroquine prevents TRAF3 degradation in osteoclast precursors and inhibits osteoclast formation in vitro and bone destruction in vivo.\",\n      \"method\": \"Conditional TRAF3-knockout mice; NIK stability assays; chloroquine treatment in vitro and in vivo (ovariectomy/PTH models)\",\n      \"journal\": \"Frontiers in Immunology (review with primary data citations)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO model with defined NIK mechanism, pharmacological rescue, multiple in vivo models\",\n      \"pmids\": [\"30323820\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TRAF3 is a multifunctional intracellular adaptor/E3 ubiquitin ligase that (1) positively regulates type I interferon production by bridging TLR/RLR adaptors (TRIF, MAVS/Cardif) to downstream kinases TBK1/IKK-ε via direct protein interactions and K63-linked auto- or trans-ubiquitination (catalyzed by HECTD3, TRIM24, and Nedd4l); (2) negatively regulates non-canonical NF-κB signaling by maintaining NIK in a degradation complex with TRAF2 and cIAP1/2, such that receptor activation causes TRAF2-dependent K48-ubiquitination and proteasomal destruction of TRAF3, releasing NIK; (3) acts as a resident nuclear protein in B cells where its TRAF-C domain inhibits CREB stability and transcription; (4) binds TAK1 to promote its ubiquitination and autophosphorylation in hepatocytes; (5) mediates ubiquitination of additional substrates (ULK1, ECH1, STAT6, MFF) to regulate autophagy, lipid metabolism, macrophage polarization, and mitochondria-dependent apoptosis; and (6) is itself regulated by deubiquitinases (OTUB1/2, OTUD7B, USP11), stabilizing factors (iOPN), and proteolytic cleavage by viral proteases (EV-D68 2Apro).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TRAF3 is a multifunctional intracellular adaptor and ubiquitin-pathway hub that couples TNF-receptor-superfamily and innate immune receptors to opposing transcriptional outputs, first identified as a direct CD40 cytoplasmic-tail binding partner whose TRAF-C domain mediates receptor binding and homodimerization [#0]. Structurally, a single adaptive hydrophobic crevice in the TRAF domain accommodates diverse partners including CD40, LTβR, BAFF-R, TANK and viral LMP1, explaining how one surface integrates many receptor inputs [#31]. In innate antiviral signaling, TRAF3 is a positive regulator of type I interferon induction, bridging TLR adaptors (MyD88, TRIF, IRAK1) and the RLR adaptor MAVS/Cardif to the IRF3/7 kinases TBK1 and IKK-ε; TRAF-domain point mutations that abolish MAVS binding also abolish IFN production [#1, #2, #3]. This bridging function depends on activating K63-linked ubiquitination of TRAF3 catalyzed by HECTD3 (at K138), TRIM24 (at K429/K436), and Nedd4l (cysteine ubiquitination at Cys56/Cys124 that licenses further K48/K63 modification and TBK1 binding), each enabling TRAF3-TBK1 complex assembly on mitochondria [#13, #20, #22]. In a counterbalancing role, TRAF3 is a critical negative regulator of non-canonical NF-κB signaling: it maintains NIK in a degradation-competent complex with TRAF2 and cIAP1/2, and receptor engagement triggers cIAP-mediated K48-ubiquitination and proteasomal destruction of TRAF3 — a step requiring the RING domain of TRAF2 — which releases and stabilizes NIK to drive p100 processing [#4, #5, #7, #8]. TRAF3 abundance is tuned by deubiquitinases that stabilize it (OTUB1/2, OTUD7B, USP11) and by stabilizing or destabilizing factors (iOPN, Parkin, Triad3A) [#6, #10, #16, #21]. Beyond these core axes, TRAF3 acts as a resident nuclear protein in B cells, where its TRAF-C-domain NLS targets it to associate with and destabilize CREB, repressing CREB-driven transcription including Mcl-1 [#12], and it ubiquitinates substrates including TAK1, STAT6, ULK1, ECH1 and MFF to control hepatic metabolism, macrophage polarization, inflammasome-driven cell death, ferroptosis, and mitochondrial apoptosis [#25, #28, #14, #30, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established TRAF3 as a direct receptor adaptor by identifying it as a CD40 cytoplasmic-tail binding protein and mapping the binding determinant.\",\n      \"evidence\": \"Yeast two-hybrid screen plus domain-deletion mapping defining the TRAF-C domain\",\n      \"pmids\": [\"7533327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define downstream signaling consequences of the interaction\", \"No structural detail of the binding interface\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined TRAF3 as a non-redundant positive node for type I IFN and IL-10 induction, linking TLR adaptors to the IRF kinases.\",\n      \"evidence\": \"Adaptor-complex isolation and TRAF3-deficient myeloid cells/fibroblasts with cytokine and virus-infection readouts\",\n      \"pmids\": [\"16306937\", \"16306936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of TBK1 recruitment by TRAF3 not resolved at molecular level\", \"Did not address how TRAF3 distinguishes IFN from pro-inflammatory output\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extended the antiviral role to RLR signaling by demonstrating a direct TRAF-domain–MAVS/Cardif interaction required for IFN production.\",\n      \"evidence\": \"In vitro binding plus TRAF-domain mutagenesis with IFN induction readout\",\n      \"pmids\": [\"16858409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish ubiquitin requirement for the MAVS-coupled function\", \"Recruitment to mitochondria not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetically established TRAF3 as the critical brake on non-canonical NF-κB by showing NIK accumulation upon TRAF3 loss and rescue of lethality by p100 deletion.\",\n      \"evidence\": \"TRAF3-/-;p100-/- double-knockout epistasis, NIK Western blotting, B cell phenotyping\",\n      \"pmids\": [\"17015635\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the biochemical mechanism of NIK turnover\", \"Roles of TRAF2/cIAP not yet incorporated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Resolved the NIK-control mechanism: TRAF3 is degraded by a TRAF2-cIAP1/2 complex upon receptor engagement, releasing NIK.\",\n      \"evidence\": \"Ubiquitination assays, cIAP1/2 and TRAF2 knockouts, receptor stimulation, proteasome inhibition\",\n      \"pmids\": [\"18997792\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which RING domain catalyzes the modification\", \"Receptor-specific kinetics not fully mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Clarified receptor competition and ligase assignment: LTβR and NIK share a TRAF3 recognition crevice, and stimulus-dependent TRAF3 degradation requires the TRAF2 RING, not TRAF3's own.\",\n      \"evidence\": \"Charge-repulsion crevice mutagenesis, Co-IP, ubiquitination and proteasome-inhibitor studies; siRNA depletion for dual canonical/non-canonical regulation\",\n      \"pmids\": [\"20348096\", \"20185819\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Medium-confidence dual-pathway claim rests on single-lab siRNA work\", \"Quantitative competition kinetics between NIK and receptor not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Provided the structural basis for TRAF3's promiscuous receptor binding via a single adaptive crevice.\",\n      \"evidence\": \"X-ray crystallography of five TRAF3 TRAF-domain complexes (CD40, LTβR, BAFF-R, TANK, LMP1)\",\n      \"pmids\": [\"17633021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures do not capture the ubiquitin-ligase or NIK-degradation complex\", \"Conformational changes during signaling not visualized\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified a nuclear function: TRAF3's TRAF-C NLS directs it to destabilize CREB and repress pro-survival transcription in B cells.\",\n      \"evidence\": \"Fractionation, Co-IP, TRAF-C mutagenesis, ubiquitination and reporter assays in B cell–specific knockouts\",\n      \"pmids\": [\"26755589\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which TRAF3 reduces CREB ubiquitination/stability not fully defined\", \"Nuclear vs cytoplasmic partitioning signals not mapped\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected TRAF3 to hepatic metabolic disease by defining a TRAF3-TAK1 ubiquitination axis driving steatosis.\",\n      \"evidence\": \"Liver-specific knockout and transgenic mice, Co-IP, ubiquitination assay, TAK1-inhibitor rescue, high-fat-diet model\",\n      \"pmids\": [\"26882989\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Linkage type of TAK1 ubiquitination not specified\", \"Tissue-selectivity of this axis vs immune cells unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined site-specific activating ubiquitination (HECTD3 at K138; TRIM24 at K429/K436) as the trigger for TRAF3-TBK1 complex formation in antibacterial/antiviral IFN responses.\",\n      \"evidence\": \"Hectd3- and Trim24-knockout mice, site-directed ubiquitination mutagenesis, Co-IP, infection models\",\n      \"pmids\": [\"29920190\", \"32324863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hierarchy and interplay among multiple K63-ligases unresolved\", \"Whether modifications are auto- or trans-catalyzed in vivo not fully settled\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed a priming layer of regulation in which Nedd4l-mediated K29-cysteine ubiquitination of TRAF3 zinc fingers licenses subsequent K48/K63 modification and TBK1 binding.\",\n      \"evidence\": \"Nedd4l-knockout mice, Cys56/Cys124 mutagenesis, K29-linkage ubiquitination assay, Co-IP, infection\",\n      \"pmids\": [\"33608556\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of cysteine vs lysine ubiquitination in vivo not resolved\", \"Reader for K29 chains not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified mitochondrial bridging and STING crosstalk: TRAF3IP3 recruits TRAF3 to MAVS, and TRAF3 couples MAVS to STING-dependent TBK1 activation, while NIK release diverts DNA-sensing output.\",\n      \"evidence\": \"Traf3ip3-knockout mice, Co-IP, mitochondrial localization; TRAF3/NIK-deficient cells with STING and NIK oligomerization assays; EV-A71 rescue experiments\",\n      \"pmids\": [\"31390091\", \"30018345\", \"36823147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Opposite RNA vs DNA pathway roles (Medium) from single lab\", \"Spatial coordination of MAVS- and STING-coupled pools unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Expanded the substrate repertoire to non-immune-receptor targets controlling cell fate and metabolism (STAT6, ULK1, ECH1, MFF).\",\n      \"evidence\": \"Site-specific ubiquitination mutagenesis, ubiquitomics, mitochondrial import assays, conditional knockouts and tumor/apoptosis models\",\n      \"pmids\": [\"37474750\", \"32275117\", \"39932808\", \"34745083\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Each substrate validated by a single lab\", \"Whether these activities require the canonical TRAF2/cIAP complex not uniformly tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapped the deubiquitinase counter-regulation that sets TRAF3 abundance and downstream pathway tone (OTUB1/2, OTUD7B, USP11; stabilizers iOPN; destabilizers Parkin/Triad3A).\",\n      \"evidence\": \"Co-IP, ubiquitination assays, catalytic-mutant and knockdown/knockout studies in viral, cancer, and ischemia models\",\n      \"pmids\": [\"19996094\", \"33198776\", \"37000116\", \"27026194\", \"29903906\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"USP11 cardiomyocyte axis is Low-confidence single study\", \"Linkage specificity removed by each DUB not uniformly defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated physiological B-cell requirement for TRAF2/TRAF3 in CD40-driven class switch recombination and germinal center formation.\",\n      \"evidence\": \"CD40 binding-site mutant transgenes in CD40-knockout mice with CSR and NF-κB readouts\",\n      \"pmids\": [\"19228877\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not separate adaptor vs ligase contributions of TRAF3\", \"Mechanistic coupling to CSR machinery unaddressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TRAF3 dynamically partitions among its opposing roles — antiviral IFN amplifier, non-canonical NF-κB brake, nuclear CREB repressor, and mitochondrial death/metabolism regulator — within a single cell remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of how ubiquitin-linkage choice routes TRAF3 to distinct fates\", \"Spatial/temporal switch between cytosolic, mitochondrial, and nuclear pools uncharacterized\", \"Hierarchy among the many competing E3 ligases and DUBs in vivo not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [5, 13, 20, 22, 25, 28, 30]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [5, 13, 20, 22]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 3, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 5, 8]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [18, 20, 29, 30]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 2, 3, 4, 5, 13, 20, 22, 33]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 7, 8, 17, 25, 27]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [5, 13, 20, 22, 28, 30]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14, 29, 32]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"complexes\": [\n      \"TRAF3-TRAF2-cIAP1/2-NIK degradation complex\",\n      \"TRAF3-TBK1 antiviral signaling complex\",\n      \"MAVS-TRAF3IP3-TRAF3 mitochondrial complex\"\n    ],\n    \"partners\": [\n      \"CD40\",\n      \"MAVS\",\n      \"TRAF2\",\n      \"TBK1\",\n      \"NIK\",\n      \"TAK1\",\n      \"STAT6\",\n      \"MFF\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```","audit_flag":null,"evaluation":{"pairwise":"loss","faith_supported":7,"faith_total":7,"faith_pct":100.0}}